HIGHLIGHTS
- who: HIV and collaborators from the The Wistar Institute, Philadelphia, Pennsylvania, USA Department of Infectious Diseases, Monash University, Melbourne, Victoria, Australia have published the Article: Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption, in the Journal: (JOURNAL) of 15/01/2021
- what: Despite these limitations, the study provides the first proof-of-concept evidence that phospholipid metabolism might be involved in a host milieu that facilitates a faster HIV rebound after ART cessation.
- future: Addressing the impact of these confounders and validating the data using larger cohorts should be . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.